N-oxides as prodrugs of piperazine and piperidine derivatives

Details for Australian Patent Application No. 2006283882 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Feenstra, Roelof W.; McCreary, Andrew C.; Hesselink, Mayke B.; Koopman, Theodorus S. M.; Koster, Hendrik J.; Van Scharrenburg, Gustaaf J. M.; Van Amsterdam, Peter H.; Verhage, Marinus

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006283882

PCT Pub. Number WO2007/023141

Priority 60/709,821 22.08.05 US; 05107671.9 22.08.05 EP

Filing date 21 August 2006

Wipo publication date 1 March 2007

Acceptance publication date 23 June 2011

International Classifications

C07D 263/58 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 295/24 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Event Publications

20 March 2008 PCT application entered the National Phase

  PCT publication WO2007/023141 Priority application(s): WO2007/023141

23 June 2011 Application Accepted

  Published as AU-B-2006283882

20 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006283884-(Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor

2006283881-Driving and steering of motor vehicles